Humana (HUM)
(Delayed Data from NYSE)
$387.38 USD
-1.51 (-0.39%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $387.35 -0.03 (-0.01%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HUM 387.38 -1.51(-0.39%)
Will HUM be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for HUM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HUM
Select Medical's (SEM) Unit Begins IPO Roadshow for 22.5M Shares
UnitedHealth Group (UNH) Beats Q2 Earnings and Revenue Estimates
HUM: What are Zacks experts saying now?
Zacks Private Portfolio Services
UnitedHealth (UNH) Pre-Q2 Earnings: Healthy Buy or a Wait-&-See?
Company News for Jul 5, 2024
Humana (HUM) Ties Up With PsychArmor for Better Veteran Care
Other News for HUM
Should You Buy Humana Stock Right Now? Here’s What Piper Sandler Expects
Dividend Champion, Contender, And Challenger Highlights: Week Of July 21
Class Action Lawsuit Against Humana Inc. (NYSE:HUM)
Humana Accelerates Commitment to Helping Seniors Choose Right Health Plan, Announces Minority Investment in Healthpilot
Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration